Algert Global LLC Reduces Stock Holdings in Cross Country Healthcare, Inc. (NASDAQ:CCRN)

Algert Global LLC lessened its holdings in shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN) by 26.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 45,661 shares of the business services provider’s stock after selling 16,513 shares during the period. Algert Global LLC owned approximately 0.14% of Cross Country Healthcare worth $614,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Boston Partners acquired a new stake in Cross Country Healthcare during the 1st quarter worth about $2,511,000. Royce & Associates LP boosted its stake in shares of Cross Country Healthcare by 51.4% in the third quarter. Royce & Associates LP now owns 1,132,566 shares of the business services provider’s stock worth $15,222,000 after buying an additional 384,374 shares during the last quarter. Pinnacle Associates Ltd. grew its holdings in Cross Country Healthcare by 14.9% during the third quarter. Pinnacle Associates Ltd. now owns 342,315 shares of the business services provider’s stock worth $4,601,000 after acquiring an additional 44,496 shares during the period. Dana Investment Advisors Inc. raised its position in Cross Country Healthcare by 34.7% during the second quarter. Dana Investment Advisors Inc. now owns 404,370 shares of the business services provider’s stock valued at $5,596,000 after acquiring an additional 104,136 shares in the last quarter. Finally, Raymond James & Associates raised its position in Cross Country Healthcare by 0.7% during the second quarter. Raymond James & Associates now owns 165,324 shares of the business services provider’s stock valued at $2,288,000 after acquiring an additional 1,155 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have recently commented on CCRN. Truist Financial dropped their price objective on shares of Cross Country Healthcare from $17.00 to $15.00 and set a “hold” rating on the stock in a research note on Monday, October 21st. Barrington Research dropped their price target on shares of Cross Country Healthcare from $21.00 to $19.00 and set an “outperform” rating on the stock in a research report on Thursday, August 8th. Finally, Benchmark lowered their target price on shares of Cross Country Healthcare from $19.00 to $18.00 and set a “buy” rating on the stock in a research note on Thursday, November 7th. Two research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $17.33.

Cross Country Healthcare Price Performance

Shares of CCRN stock opened at $10.76 on Friday. Cross Country Healthcare, Inc. has a 1-year low of $9.58 and a 1-year high of $23.64. The stock has a 50 day simple moving average of $11.79 and a 200-day simple moving average of $13.68. The company has a market cap of $354.19 million, a price-to-earnings ratio of -215.20, a PEG ratio of 2.06 and a beta of 0.65.

Cross Country Healthcare Profile

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.